Literature DB >> 18669716

Vulvodynia incidence and remission rates among adult women: a 2-year follow-up study.

Barbara D Reed1, Hope K Haefner, Ananda Sen, Daniel W Gorenflo.   

Abstract

OBJECTIVE: To estimate the incidence and remission rates of vulvodynia over a 2-year period.
METHODS: A 2-year follow-up survey was sent to the University of Michigan Women's Health Registry members who had participated in a previously reported, validated survey. Changes in clinical status, incidence, and remission rates for vulvodynia were estimated, as were factors associated with new onset or remission of symptoms, using univariable and multivariable analyses.
RESULTS: Of 1,037 women enrolled in the initial study, 744 women (71.7%) completed an online or written follow-up survey between September 2006 and March 2007. Of the 372 asymptomatic women controls at initial enrollment, 13 (3.5%, 95% confidence interval 1.6-5.4%) had developed vulvodynia during the 2-year follow-up period; nine (2.2%) of these had ongoing symptoms. Of 45 women with vulvodynia at initial enrollment, 10 (22.2%, 95% confidence interval 10.1-34.4%) indicated their symptoms had resolved. Factors at enrollment that were associated with incidence of vulvodynia were younger age and history of pain after intercourse. Remission was more common in women who did not have pain after intercourse and in those who reported less severe pain at enrollment.
CONCLUSION: Based on 2-year follow-up, each year approximately one in 50 women develop symptoms of vulvodynia, and one in 10 women with vulvodynia report remission of symptoms.

Entities:  

Mesh:

Year:  2008        PMID: 18669716     DOI: 10.1097/AOG.0b013e318180965b

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  18 in total

1.  Remission of vulvar pain among women with primary vulvodynia.

Authors:  Ruby H N Nguyen; Charu Mathur; Erin M Wynings; David A Williams; Bernard L Harlow
Journal:  J Low Genit Tract Dis       Date:  2015-01       Impact factor: 1.925

Review 2.  A psychosocial approach to female genital pain.

Authors:  Marieke Dewitte; Charmaine Borg; Lior Lowenstein
Journal:  Nat Rev Urol       Date:  2017-11-28       Impact factor: 14.432

3.  Factors associated with vulvodynia incidence.

Authors:  Barbara D Reed; Laurie J Legocki; Melissa A Plegue; Ananda Sen; Hope K Haefner; Sioban D Harlow
Journal:  Obstet Gynecol       Date:  2014-02       Impact factor: 7.661

4.  Remission, Relapse, and Persistence of Vulvodynia: A Longitudinal Population-Based Study.

Authors:  Barbara D Reed; Sioban D Harlow; Melissa A Plegue; Ananda Sen
Journal:  J Womens Health (Larchmt)       Date:  2016-01-11       Impact factor: 2.681

5.  Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trial.

Authors:  David C Foster; Merrill Beth Kotok; Li-Shan Huang; Arthur Watts; David Oakes; Fred M Howard; Ellen L Poleshuck; Chris J Stodgell; Robert H Dworkin
Journal:  Obstet Gynecol       Date:  2010-09       Impact factor: 7.661

6.  Prevalence and demographic characteristics of vulvodynia in a population-based sample.

Authors:  Barbara Diane Reed; Siobán Denise Harlow; Ananda Sen; Laurie Jo Legocki; Rayna Monique Edwards; Nora Arato; Hope Katharine Haefner
Journal:  Am J Obstet Gynecol       Date:  2011-08-22       Impact factor: 8.661

7.  Rationale and design of a multicenter randomized clinical trial of extended release gabapentin in provoked vestibulodynia and biological correlates of response.

Authors:  Candace S Brown; David C Foster; Jim Y Wan; Leslie A Rawlinson; Gloria A Bachmann
Journal:  Contemp Clin Trials       Date:  2013-06-29       Impact factor: 2.226

8.  Oral contraceptive use and risk of vulvodynia: a population-based longitudinal study.

Authors:  B D Reed; S D Harlow; L J Legocki; M E Helmuth; H K Haefner; B W Gillespie; A Sen
Journal:  BJOG       Date:  2013-08-13       Impact factor: 6.531

9.  Prevalence of symptoms consistent with a diagnosis of vulvodynia: population-based estimates from 2 geographic regions.

Authors:  Bernard L Harlow; Christine G Kunitz; Ruby H N Nguyen; Sarah A Rydell; Rachel M Turner; Richard F MacLehose
Journal:  Am J Obstet Gynecol       Date:  2013-09-28       Impact factor: 8.661

10.  Augmented central pain processing in vulvodynia.

Authors:  Johnson P Hampson; Barbara D Reed; Daniel J Clauw; Rupal Bhavsar; Richard H Gracely; Hope K Haefner; Richard E Harris
Journal:  J Pain       Date:  2013-04-09       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.